Troponins and natriuretic peptides in the monitoring of anthracycline cardiotoxicity

被引:38
作者
Germanakis, Ioannis [1 ]
Anagnostatou, Nikol [2 ]
Kalmanti, Maria [2 ]
机构
[1] Univ Hosp Heraklion, Dept Pediat, Pediat Cardiol Unit, Iraklion, Greece
[2] Univ Hosp Heraklion, Dept Pediat Hematol Oncol, Iraklion, Greece
关键词
biological markers; cardiotoxicity after cancer therapy; diagnostic tools; late effects; natriuretic peptides; troponin;
D O I
10.1002/pbc.21633
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Anthracycline-related cardiotoxicity has a substantial negative impact on long-term survivors of childhood cancer. The detection of cardiotoxicity is currently based on echocardiography or radionuclide angiography. However, as they depict only the final outcome of myocardial injury in terms of reduced heart contractility, heart specific biomarkers of myocardial destruction or dysfunction could be advantageous by allowing for an earlier detection of cardiotoxicity. In the present study, the usefulness of cardiac troponins and natriuretic peptides, the most commonly used biomarkers of myocardial destruction and ventricular dysfunction respectively, to detect and to predict the development of anthracycline cardiotoxicity has been reviewed.
引用
收藏
页码:327 / 333
页数:7
相关论文
共 66 条
[11]   NATRIURETIC PEPTIDES INHIBIT DNA-SYNTHESIS IN CARDIAC FIBROBLASTS [J].
CAO, L ;
GARDNER, DG .
HYPERTENSION, 1995, 25 (02) :227-234
[12]   Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy [J].
Cardinale, D ;
Sandri, MT ;
Martinoni, A ;
Tricca, A ;
Civelli, M ;
Lamantia, G ;
Cinieri, S ;
Martinelli, G ;
Cipolla, CM ;
Fiorentini, C .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (02) :517-522
[13]   Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy [J].
Cardinale, D ;
Sandri, MT ;
Colombo, A ;
Colombo, N ;
Boeri, M ;
Lamantia, G ;
Civelli, M ;
Peccatori, F ;
Martinelli, G ;
Fiorentini, C ;
Cipolla, CM .
CIRCULATION, 2004, 109 (22) :2749-2754
[14]   Myocardial injury revealed by plasma troponin I in breast cancer treated with high-dose chemotherapy [J].
Cardinale, D ;
Sandri, MT ;
Martinoni, A ;
Borghini, E ;
Civelli, M ;
Lamantia, G ;
Cinieri, S ;
Martinelli, G ;
Fiorentini, C ;
Cipolla, CM .
ANNALS OF ONCOLOGY, 2002, 13 (05) :710-715
[15]   Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides: A review [J].
Clerico, A ;
Emdin, M .
CLINICAL CHEMISTRY, 2004, 50 (01) :33-50
[16]   The circulating levels of cardiac natriuretic hormones in healthy adults: Effects of age and sex [J].
Clerico, A ;
Del Ry, S ;
Maffei, S ;
Prontera, C ;
Emdin, M ;
Giannessi, D .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2002, 40 (04) :371-377
[17]   Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care [J].
Cowie, MR ;
Struthers, AD ;
Wood, DA ;
Coats, AJS ;
Thompson, SG ;
PooleWilson, PA ;
Sutton, GC .
LANCET, 1997, 350 (9088) :1349-1353
[18]   CARDIAC TROPONIN-T AND CREATINE-KINASE MB MASS CONCENTRATIONS IN CHILDREN RECEIVING ANTHRACYCLINE CHEMOTHERAPY [J].
FINK, FM ;
GENSER, N ;
FINK, C ;
FALK, M ;
MAIR, J ;
MAURERDENGG, K ;
HAMMERER, I ;
PUSCHENDORF, B .
MEDICAL AND PEDIATRIC ONCOLOGY, 1995, 25 (03) :185-189
[19]   Childhood cancer survival in Europe and the United States [J].
Gatta, G ;
Capocaccia, R ;
Coleman, MP ;
Ries, LAG ;
Berrino, F .
CANCER, 2002, 95 (08) :1767-1772
[20]   Correlation of plasma N-terminal pro-brain natriuretic peptide levels with left ventricle mass in children treated with anthracyclines [J].
Germanakis, I ;
Kalmanti, M ;
Parthenakis, F ;
Nikitovic, D ;
Stiakaki, E ;
Patrianakos, A ;
Vardas, PE .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2006, 108 (02) :212-215